Dotcompharma.com is excited to announce the addition of Generic Cymbalta to the list of antidepressants offered
Online PR News – 13-January-2011 – – Dotcompharma.com is excited to announce the addition of Generic Cymbalta to the list of antidepressants offered
January 12, 2010 - New York, New York - Dotcompharma is always striving to locate the next best thing in all medical realms, and that includes antidepressant medication. While Dotcompharma does offer a wide variety of SSRI medications, it is happy to announce that it is starting to stock different alternatives, including the addition of Generic Cymbalta to that list.
The medical staff at Dotcompharma is very excited for this new addition that will offer individuals more choice in the antidepressant medication they choose to use. Unlike the other medications to treat depression offered, Generic Cymbalta is an SSRNI - or a selective serotonin norepinephrine reuptake inhibitor. It is one of the most trusted antidepressant medications available to relieve the physiological and psychological symptoms of depression.
"Many individuals are looking for an alternative to SSRI antidepressant medication," said Dotcompharma company manager Joseph Frankel. "SSRIs can often lack in effectiveness and leaves individuals with many unwanted negative side effects. As we are always trying to improve for the sake of our clients, we began stocking Generic Cymbalta which has increased effectiveness and less harsh side effects. We are very pleased that customers are taking so positively to this new addition to our ranks."
There are medical professionals around the clock to answer questions anyone has before they buy Generic Cymbalta online, including if Generic Cymbalta is the right medication to treat depression. They also assist in selecting the dosage that is right for personal needs of each individual client.
Generic Cymbalta is an FDA approved medication used to relieve different forms of depression as well as fibromyalgia and diabetic neuropathy.